Table 2

Fall risk variables

VariableDescription
Polyfarmacy
ATCuniqueNumber of unique ATC codes
ATCunique≥5Presence of 5 or more unique ATC codes (yes=1, no=0)
ATCunique 0–5Presence of 0–5 unique ATC codes (yes=1, no=0)
ATCunique 5–10Presence of 5–10 unique ATC codes (yes=1, no=0)
ATCunique10 - 15Presence of 10–15 unique ATC codes (yes=1, no=0)
ATCunique≥15Presence of 15 or more unique ATC codes (yes=1, no=0)
Resident characteristics
GenderMale/female
AgeAge in years
Age_cAge in years, centred
Age_c2Age in years, centred quadratic term
Presence of specific ATC codes (yes=1, no=0)
A02BDrugs for peptic ulcer and gastro-oesophageal reflux disease (GORD)
A10Drugs used in diabetes
C01Cardiac therapy
C01ACardiac glycosides
C01BAntiarrhythmics, classes I and III
C01CCardiac stimulants excl. cardiac glycosides
C01DVasodilators used in cardiac diseases
C02Antihypertensives
C03Diuretics (cardiovascular system)
C04ACNicotinic acid and derivatives (peripheral vasodilators)
C07Beta blocking agents (cardiovascular system)
C08Calcium channel blockers (cardiovascular system)
C09Agents acting on the renin-angiotensin system
C10Lipid modifying agents
G04Urologicals
G04CAAlpha-adrenoreceptor antagonists (urologicals)
M01AAntiinflammatory and antirheumatic products, non-steroids
M03Muscle relaxants
N02AOpioids (analgetics)
N02BOther analgesics and antipyretics
N03AAntiepileptics
N04Anti-Parkinson drugs
N04AAnticholinergic agents (anti-Parkinson drugs)
N05AAntipsychotics
N05BAnxiolytics
N05CHypnotics and sedatives
N06AAntidepressants
N06DAntidementia drugs
N06DAAnticholinesterases (psychoanaleptics)
N07AAAnticholinesterases (parasympathomimetics)
N07CAntivertigo preparations
R01BASympathomimetics (respiratory system)
R06AAntihistamines for systemic use
S01EDBeta blocking agents (ophthalmologicals)
  • ATC, Anatomical Therapeutic Chemical.